BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6752789)

  • 1. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions].
    Wittekind C; von Kleist S; Sandritter W
    Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carcinoembryonic antigen in serum and tissue of benign and cancerous breast lesions].
    von Kleist S; Wittekind C; Polack M; Gropp H; Sandritter W
    Arch Geschwulstforsch; 1981; 51(6):523-6. PubMed ID: 6277268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEA positivity in tissue and sera of patients with benign breast lesions.
    Wittekind C; Von Kleist S; Sandritter W
    Oncodev Biol Med; 1981; 2(6):381-90. PubMed ID: 7346797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoperoxidase detection of carcinoembryonic antigen in fine needle aspirates of breast carcinoma. Correlation with studies in tissue sections.
    Murthy L; Kapila K; Verma K
    Acta Cytol; 1988; 32(1):60-2. PubMed ID: 3276079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEA and NCA in benign and malignant breast tumors.
    Nap M; Keuning H; Burtin P; Oosterhuis JW; Fleuren G
    Am J Clin Pathol; 1984 Nov; 82(5):526-34. PubMed ID: 6388310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative immunohistological studies of the localization of the carcinoembryonic antigen in benign and malignant breast tissue].
    Wittekind C; von Kleist S; Sandritter W
    Acta Histochem Suppl; 1982; 25():83-7. PubMed ID: 6806865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoembryogenic antigen (CEA) and lactoferrin (LF) in benign and malignant disease of the breast. A contribution to the immuno-histological demonstration of marker substances (author's transl)].
    Wurster K; Heberling D; Rapp W
    Geburtshilfe Frauenheilkd; 1980 May; 40(5):412-22. PubMed ID: 6250937
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
    Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen staining in breast carcinoma by PAP methods compared to CEA and ferritin staining.
    Osamu K; Takashi M; Yohichi T; Yasuo U; Tetsuro Y; Yoshiro F; Toshio T
    Cancer Detect Prev; 1987; 10(1-2):113-20. PubMed ID: 2436774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of immuno-electron microscopy to the cytologic study of benign and malignant mammary lesions. With special reference to the carcinoembryonic antigen localization patterns.
    Yamamoto Y; Yasumura K; Murakoshi M; Abe H; Furukawa S; Osamura RY; Watanabe K
    Acta Cytol; 1985; 29(3):257-61. PubMed ID: 2988246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic (CEA)--like antigen in adenomas and cancers of the breast in human patients.
    Potomski J; Harlozińska A; Richter R; Starzyk H
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):461-8. PubMed ID: 92973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relevance of CEA in benign breast disease (author's transl)].
    Opri F; Kirchner H; Mayfeld K
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):51-4. PubMed ID: 7353775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrastructural study of carcinoembryonic antigen (CEA) using the peroxidase-antiperoxidase (PAP) complex technic in patients with breast cancer].
    Grzanka A; Domaniewski J
    Patol Pol; 1989; 40(3):325-33. PubMed ID: 2701332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinoma.
    Shousha S; Lyssiotis T
    Histopathology; 1978 Nov; 2(6):433-47. PubMed ID: 365699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of carcinoembryonic antigen immunoreactivity from isolated ductal hyperplasias to atypical hyperplasias associated with infiltrating ductal breast cancer.
    Schmitt FC; Andrade L
    J Clin Pathol; 1995 Jan; 48(1):53-6. PubMed ID: 7706519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
    Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
    Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
    [No Abstract]   [Full Text] [Related]  

  • 19. Isoantigens A, B and H in benign and malignant lesions of breast.
    Gupta RK; Schuster R
    Am J Pathol; 1973 Aug; 72(2):253-7. PubMed ID: 4807589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical detection of carcinoembryonic antigen in fine-needle aspirates from patients with diverse breast diseases.
    Alexiev BA; Valkov IN; Popov AA; Marinov VS
    Diagn Cytopathol; 1993 Aug; 9(4):377-82. PubMed ID: 8261842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.